Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Parisi

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Acta Bio-Medica : Atenei Parmensis|October 27, 2022
Positive impact of insulin treatment on clinical trend in cystic fibrosis patients: a retrospective studyAndrea Giugno, Salvatore Leonardi, Donatella Lo Presti, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|November 25, 2020
Upper airway involvement in pediatric COVID-19Giuseppe Fabio Parisi, Giulia Brindisi, Cristiana Indolfi, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|January 26, 2022
COVID-19, anosmia, and ageusia in atopic childrenGiuseppe Fabio Parisi, Giulia Brindisi, Cristiana Indolfi, et al.
Molecular Cell|March 12, 2014
Oct-1 regulates IL-17 expression by directing interchromosomal associations in conjunction with CTCF in T cellsLark Kyun Kim, Enric Esplugues, Cornelia E Zorca, et al.
Pigment Cell & Melanoma Research|February 13, 2010
PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cellsRuth Halaban, Wengeng Zhang, Antonella Bacchiocchi, et al.
Clinical and Molecular Allergy : CMA|March 5, 2020
Cetirizine use in childhood: an update of a friendly 30-year drugGiuseppe Fabio Parisi, Salvatore Leonardi, Giorgio Ciprandi, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 19, 2016
YKL-40 as marker of severe lung disease in cystic fibrosis patientsSalvatore Leonardi, Giuseppe Fabio Parisi, Antonino Capizzi, et al.
Immunobiology|December 26, 2016
Severe disease in Cystic Fibrosis and fecal calprotectin levelsGiuseppe Fabio Parisi, Maria Papale, Novella Rotolo, et al.
Allergy and Asthma Proceedings|January 7, 2015
Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): association with clinical severity and phenotypeSalvatore Leonardi, Caterina Cuppari, Sara Manti, et al.
Acta Bio-Medica : Atenei Parmensis|May 12, 2022
Addition of a nutraceutical to montelukast or inhaled steroid in the treatment of wheezing during COVID-19 pandemic: a multicenter, open-label, randomized controlled trialGiuseppe Fabio Parisi, Sara Manti, Maria Papale, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Acta Bio-Medica : Atenei Parmensis|October 27, 2022
Positive impact of insulin treatment on clinical trend in cystic fibrosis patients: a retrospective studyAndrea Giugno, Salvatore Leonardi, Donatella Lo Presti, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|November 25, 2020
Upper airway involvement in pediatric COVID-19Giuseppe Fabio Parisi, Giulia Brindisi, Cristiana Indolfi, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|January 26, 2022
COVID-19, anosmia, and ageusia in atopic childrenGiuseppe Fabio Parisi, Giulia Brindisi, Cristiana Indolfi, et al.
Molecular Cell|March 12, 2014
Oct-1 regulates IL-17 expression by directing interchromosomal associations in conjunction with CTCF in T cellsLark Kyun Kim, Enric Esplugues, Cornelia E Zorca, et al.
Pigment Cell & Melanoma Research|February 13, 2010
PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cellsRuth Halaban, Wengeng Zhang, Antonella Bacchiocchi, et al.
Clinical and Molecular Allergy : CMA|March 5, 2020
Cetirizine use in childhood: an update of a friendly 30-year drugGiuseppe Fabio Parisi, Salvatore Leonardi, Giorgio Ciprandi, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 19, 2016
YKL-40 as marker of severe lung disease in cystic fibrosis patientsSalvatore Leonardi, Giuseppe Fabio Parisi, Antonino Capizzi, et al.
Immunobiology|December 26, 2016
Severe disease in Cystic Fibrosis and fecal calprotectin levelsGiuseppe Fabio Parisi, Maria Papale, Novella Rotolo, et al.
Allergy and Asthma Proceedings|January 7, 2015
Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): association with clinical severity and phenotypeSalvatore Leonardi, Caterina Cuppari, Sara Manti, et al.
Acta Bio-Medica : Atenei Parmensis|May 12, 2022
Addition of a nutraceutical to montelukast or inhaled steroid in the treatment of wheezing during COVID-19 pandemic: a multicenter, open-label, randomized controlled trialGiuseppe Fabio Parisi, Sara Manti, Maria Papale, et al.
Pageof 11